Subscribe to Hello Pharma’s news feed.
Click on “Follow” and decide if you want to get news from Hello Pharma via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Hello Pharma comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Hello Pharma which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: For Pharmaceutical Brands: New-age Media & Digital Marketing Platform
Is this your feed? Claim it!
As global pharmaceutical supply chains continue to diversify, Indian manufacturers are increasingly exploring new international markets to strengthen exports and build strategic partnerships. One of the most promising destinations is Russia, where demand for pharmaceutical products, ingredients, manufacturing technologies and laboratory solutions continues to grow.
...
For decades, India’s pharmaceutical success story has been told through the lens of drug manufacturers, biotechnology breakthroughs, and healthcare innovation. Yet beneath every regulated manufacturing plant, every sterile facility, and every life saving medicine lies an industry that rarely makes headlines, the engineers, equipment manufacturers, cleanroom specialists, and t...
1. For a long time, pharmaceutical engineering developed largely on its own. That’s changing fast. The boundaries between pharma, biotech, food processing, chemicals, renewable energy, and advanced manufacturing are fading. Looking across these industries, what are the most useful engineering lessons they’re learning from each other, and which ones do you think they s...
Mumbai, India: The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, reaffirming its position as one of India’s leading knowledge-sharing platforms dedicated to pharmacovigilance, drug safety, regulatory affairs, and patient safety.
The two-day symposium brought together s...
The pharmaceutical industry’s centre of gravity is shifting. High-potency active pharmaceutical ingredients (HPAPIs), antibody-drug conjugates, oncology injectables, and cell-therapy products now form the backbone of late-stage pipelines. Each of these categories presents the same dual challenge: nanogram-level operator exposure limits on one side, ISO 5 / Grade A sterility o...